ITI News Archive
Stanford Medicine News
Antibody treatment for ‘bubble boy’ disease
In a clinical trial, participants were given an antibody to CD117, a cell surface marker, in an effort to wipe out their defective blood stem cells without high-risk chemotherapy or radiation.
Iron triggers lung transplant infection
Iron enables a common mold to take root in lung transplant recipients, according to Stanford researchers who led a study that offers a new perspective for understanding and treating these pulmonary infections.
Schneider on disease and data sculptures
Many infectious diseases, including malaria, are marked by cyclical ups and downs. David Schneider takes a creative approach to making sense of those ups and downs.
'Vaccine’ destroys tumors in mice
Activating T cells in tumors eliminated even distant metastases in mice, Stanford researchers found. Lymphoma patients are being recruited to test the technique in a clinical trial.
50th-anniversary celebration of heart transplant
The landmark heart transplant performed at Stanford in 1968 ultimately led to the success of the operation around the world today.
Landmark heart surgery changed history
On Jan. 6, 1968, as Stanford surgeon Norman Shumway performed the first U.S. adult heart transplantation, the world held its breath.
Screen could reveal immunotherapy targets
Stanford scientists have developed a biochemical screen that identifies molecules critical to immunotherapy for a host of diseases, including cancer.
Drug blocks several mosquito-borne viruses
A new Stanford study details how to shut off proteins in mammalian cells to keep viruses such as Zika, dengue and West Nile from replicating in them.
Multiple food allergies treated safely
Combining an antibody drug, omalizumab, with a procedure to desensitize children to multiple food allergies is safe and effective, according to a new study by Stanford researchers.
Second ‘don’t eat me’ signal found on cancer
CD47 is an important inhibitor of cancer-killing immune cells called macrophages. Now Stanford researchers have identified another, similar way to activate macrophages to destroy cancer cells.